TELA Bio, Inc.·4

Feb 23, 4:13 PM ET

Smeykal Megan 4

4 · TELA Bio, Inc. · Filed Feb 23, 2024

Insider Transaction Report

Form 4
Period: 2024-02-21
Smeykal Megan
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2024-02-21$7.00/sh795$5,56520,658 total
  • Award

    Common Stock

    2024-02-21+9,40030,058 total
Footnotes (3)
  • [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
  • [F2]Includes 1,022 shares acquired under the Company's employee stock purchase plan on January 31, 2024.
  • [F3]These restricted stock units will vest in four equal annual installments beginning on February 21, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES